Bulletin
Investor Alert

New York Markets Close in:

Semler Scientific Inc.

OTC: SMLR

GO
/marketstate/country/us

Market open

 --Quotes are delayed by 20 min

May 18, 2021, 11:40 a.m.

/zigman2/quotes/201267132/composite

$

107.60

Change

+2.59 +2.46%

Volume

Volume 1,636

Quotes are delayed by 20 min

/zigman2/quotes/201267132/composite

Previous close

$ 105.01

$ 107.60

Change

+2.59 +2.46%

Day low

Day high

$105.20

$107.60

Open

52 week low

52 week high

$40.22

$118.97

Open

Company Description

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluate its customers patients for chronic disease, including heart attacks and strokes, us...

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluate its customers patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.

Valuation

P/E Current

60.47

P/E Ratio (with extraordinary items)

52.92

P/E Ratio (without extraordinary items)

54.14

Price to Sales Ratio

19.64

Price to Book Ratio

21.14

Price to Cash Flow Ratio

49.18

Enterprise Value to EBITDA

44.51

Enterprise Value to Sales

19.07

Efficiency

Revenue/Employee

448,872.00

Income Per Employee

162,872.00

Receivables Turnover

12.27

Total Asset Turnover

1.46

Liquidity

Current Ratio

5.82

Quick Ratio

5.82

Cash Ratio

4.89

Profitability

Gross Margin

91.31

Operating Margin

41.35

Pretax Margin

42.71

Net Margin

36.28

Return on Assets

52.93

Return on Equity

65.35

Return on Total Capital

74.47

Return on Invested Capital

65.35

Capital Structure

Officers and Executives

Name Age Officer Since Title
Dr. Douglas R. Murphy-Chutorian 65 2012 Director
Mr. Andrew B. Weinstein 55 2017 Vice President-Accounting
Mr. Robert G. McRae 50 2010 Chief Technical Officer
Mr. Daniel E. Conger 42 2010 Vice President-Finance
Dr. Herbert J. Semler 90 2007 Chairman

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/10/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1   Disposition at $112.39 per share. 112
05/10/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
449   Disposition at $109.54 per share. 49,183
05/10/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
200   Disposition at $107.01 per share. 21,402
05/10/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
600   Disposition at $104.97 per share. 62,982
05/10/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Derivative/Non-derivative trans. at $0.52 per share. 650
05/03/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
100   Disposition at $116 per share. 11,600
05/03/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
100   Disposition at $115 per share. 11,500
05/03/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
106   Disposition at $112.97 per share. 11,974
05/03/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
300   Disposition at $111.33 per share. 33,399
05/03/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
244   Disposition at $110.47 per share. 26,954
05/03/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
400   Disposition at $109.16 per share. 43,664
05/03/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Derivative/Non-derivative trans. at $0.52 per share. 650
04/26/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
200   Disposition at $114.02 per share. 22,804
04/26/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
503   Disposition at $113.02 per share. 56,849
04/26/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
547   Disposition at $112.38 per share. 61,471
04/26/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Derivative/Non-derivative trans. at $0.52 per share. 650
04/19/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Disposition at $109.84 per share. 137,300
04/19/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Derivative/Non-derivative trans. at $0.52 per share. 650
04/12/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Disposition at $108.21 per share. 135,262
04/12/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Derivative/Non-derivative trans. at $0.52 per share. 650
04/05/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Disposition at $107.21 per share. 134,012
04/05/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Derivative/Non-derivative trans. at $0.52 per share. 650
03/29/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
444   Disposition at $112.7 per share. 50,038
03/29/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
2   Disposition at $111.5 per share. 223
03/29/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
504   Disposition at $110.78 per share. 55,833
03/29/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
300   Disposition at $109.01 per share. 32,703
03/29/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Derivative/Non-derivative trans. at $0.52 per share. 650
03/22/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
4   Disposition at $111 per share. 444
03/22/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
53   Disposition at $110 per share. 5,830
03/22/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
693   Disposition at $108 per share. 74,844
03/22/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
150   Disposition at $106 per share. 15,900
03/22/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
300   Disposition at $105 per share. 31,500
03/22/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
50   Disposition at $104.02 per share. 5,201
03/22/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Derivative/Non-derivative trans. at $0.52 per share. 650
03/15/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
50   Disposition at $108 per share. 5,400
03/15/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
200   Disposition at $107 per share. 21,400
03/15/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
366   Disposition at $101.92 per share. 37,302
03/15/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
634   Disposition at $101.03 per share. 64,053
03/15/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Derivative/Non-derivative trans. at $0.52 per share. 650
03/08/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
200   Disposition at $100.3 per share. 20,060
03/08/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
200   Disposition at $100 per share. 20,000
03/08/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
50   Disposition at $99 per share. 4,950
03/08/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
150   Disposition at $97.72 per share. 14,658
03/08/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
650   Disposition at $95.91 per share. 62,341
03/08/2021 Douglas R. Murphy-Chutorian
Chief Executive Officer; Director
1,250   Derivative/Non-derivative trans. at $0.52 per share. 650
/news/latest/company/us/smlr

MarketWatch News on SMLR

  1. Semler Scientific stock price target raised to $121 from $100 at B. Riley

    9:43 a.m. Feb. 25, 2021

    - Tomi Kilgore

  2. Semler Scientific started at buy with $61 stock price target at B. Riley FBR

    7:45 a.m. June 23, 2020

    - Tomi Kilgore

/news/nonmarketwatch/company/us/smlr

Other News on SMLR

  1. 10-Q: SEMLER SCIENTIFIC, INC.

    7:43 a.m. May 7, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  2. Omnicell (OMCL) Q1 Earnings Beat Estimates, Margins Expand

    10:29 a.m. April 30, 2021

    - Zacks.com

  3. LabCorp (LH) Q1 Earnings Surpass Estimates, View Raised

    11:59 a.m. April 29, 2021

    - Zacks.com

  4. Amedisys (AMED) Q1 Earnings Beat Estimates, 2021 View Up

    9:11 a.m. April 29, 2021

    - Zacks.com

  5. Chemed (CHE) Q1 Earnings Beat Estimates, Gross Margin Up

    1:30 p.m. April 28, 2021

    - Zacks.com

  6. Boston Scientific (BSX) Q1 Earnings Beat, Organic Sales Up

    11:28 a.m. April 28, 2021

    - Zacks.com

  7. HOLX vs. SMLR: Which Stock Should Value Investors Buy Now?

    11:40 a.m. April 6, 2021

    - Zacks.com

  8. Fed Eyes Faster Recovery in 2021: 3 MedTech Stocks to Buy

    10:06 a.m. March 19, 2021

    - Zacks.com

  9. Loading more headlines...

At a Glance

Semler Scientific, Inc.

2340-2348 Walsh Avenue

Suite 2344

Santa Clara, California 95051

Phone

1 8777744211

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2021

Revenue

$38.60M

Net Income

$14.01M

2020 Sales Growth

17.8%

Employees

86.00

/news/pressrelease/company/us/smlr

Press Releases on SMLR

  1. Semler Reports First Quarter 2021 Financial Results

    4:01 p.m. May 3, 2021

    - PR Newswire - PRF

  2. Semler Scientific, Inc. to Host Earnings Call

    3:30 p.m. March 1, 2021

    - ACCESSWIRE

  3. Semler Scientific, Inc. to Host Earnings Call

    2:16 p.m. Nov. 5, 2020

    - ACCESSWIRE

  4. Semler to Participate in Upcoming Investor Conferences

    8:03 a.m. Sept. 8, 2020

    - PR Newswire - PRF

  5. Semler Reports Second Quarter and First Half 2020 Financial Results

    4:01 p.m. Aug. 3, 2020

    - PR Newswire - PRF

Link to MarketWatch's Slice.